UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 9/2011, Volume 66, Issue 9, pp. 2107 - 2111
HIV/AIDS | Older patients | Drug-drug interactions | Polypharmacy | Cardiovascular drugs | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Immunopathology | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Immunodeficiencies. Immunoglobulinopathies | Immunodeficiencies | Antibiotics. Antiinfectious agents. Antiparasitic agents | Central Nervous System Agents - therapeutic use | Follow-Up Studies | Humans | Middle Aged | Antiretroviral Therapy, Highly Active - adverse effects | Hormones - therapeutic use | Methadone - therapeutic use | Male | Narcotics - therapeutic use | Hormones - adverse effects | Central Nervous System Agents - adverse effects | Narcotics - adverse effects | Socioeconomic Factors | Drug Interactions | Adult | Anti-HIV Agents - therapeutic use | Female | Substance Abuse, Intravenous - complications | Anti-HIV Agents - adverse effects | HIV Infections - virology | Substance-Related Disorders - complications | Cardiovascular Agents - therapeutic use | Drug Prescriptions - statistics & numerical data | Aging - physiology | Switzerland - epidemiology | Gastrointestinal Agents - therapeutic use | HIV Infections - complications | HIV Infections - drug therapy | Aged | Gastrointestinal Agents - adverse effects | Methadone - adverse effects | Cardiovascular Agents - adverse effects | Cohort Studies | Antiretroviral drugs | Comparative analysis | Human immunodeficiency virus--HIV | Risk assessment | Index Medicus
Journal Article
Cardiovascular toxicology, ISSN 1530-7905, 2001
Journal
Journal of hepatology, ISSN 0168-8278, 2012, Volume 58, Issue 4, pp. 792 - 800
Gastroenterology and Hepatology | Boceprevir | Hepatitis C virus infection | Telaprevir | Pharmacokinetics | Drug interactions | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Hepatitis C, Chronic - metabolism | Antiviral Agents - pharmacokinetics | Hypnotics and Sedatives - adverse effects | Humans | Hypnotics and Sedatives - administration & dosage | Drug Interactions | Hypoglycemic Agents - administration & dosage | Drug Therapy, Combination | Immunosuppressive Agents - administration & dosage | Cardiovascular Agents - administration & dosage | Anti-Infective Agents - adverse effects | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Opiate Substitution Treatment - adverse effects | Buprenorphine - administration & dosage | Anti-Infective Agents - administration & dosage | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Antiviral Agents - adverse effects | Buprenorphine - adverse effects | Antidepressive Agents - administration & dosage | Immunosuppressive Agents - adverse effects | Methadone - administration & dosage | Methadone - adverse effects | Antidepressive Agents - adverse effects | Cardiovascular Agents - adverse effects | Hypoglycemic Agents - adverse effects | Hepatitis C virus | Index Medicus
Journal Article
04/2000, Volume 22, Issue 4, 40
Mitomycin, adverse reactions | Tretinoin, adverse reactions | Etoposide, adverse reactions | Cladribine, adverse reactions | Heart disorders, drug-induced | Pentostatin, adverse reactions | Vinca alkaloids, adverse reactions | Cytostatic antibiotics, adverse reactions | Fluorouracil, adverse reactions | Asparaginase, adverse reactions | Cisplatin, adverse reactions | Carmustine, adverse reactions | Amsacrine, adverse reactions | Ifosfamide, adverse reactions | Mitoxantrone, adverse reactions | Cyclophosphamide, adverse reactions | Cytarabine, adverse reactions | Paclitaxel, adverse reactions | Teniposide, adverse reactions | Antineoplastics, adverse reactions | Busulfan, adverse reactions | Chlormethine, adverse reactions | Pharmacology & Pharmacy | Public, Environmental & Occupational Health | Toxicology | Life Sciences & Biomedicine | Science & Technology | Biological and medical sciences | Medical sciences | Drug toxicity and drugs side effects treatment | Toxicity: cardiovascular system | Pharmacology. Drug treatments | Antineoplastic Agents - adverse effects | Humans | Risk Factors | Antimetabolites, Antineoplastic - adverse effects | Antibiotics, Antineoplastic - adverse effects | Heart Diseases - prevention & control | Antineoplastic Agents, Alkylating - adverse effects | Heart Diseases - chemically induced | Angiogenesis Inhibitors - adverse effects | Index Medicus
Book Review
Journal of thrombosis and haemostasis, ISSN 1538-7933, 06/2020, Volume 18, Issue 6, pp. 1320 - 1323
plasma level | anticoagulant | COVID‐19 | antiviral agents | DOAC | Peripheral Vascular Disease | Life Sciences & Biomedicine | Hematology | Cardiovascular System & Cardiology | Science & Technology | Betacoronavirus - pathogenicity | Dabigatran - adverse effects | Dabigatran - administration & dosage | Coronavirus Infections - drug therapy | Humans | Pneumonia, Viral - drug therapy | Male | Antithrombins - administration & dosage | Pyridones - blood | Thiazoles - adverse effects | Factor Xa Inhibitors - administration & dosage | COVID-19 | Pyridines - adverse effects | SARS-CoV-2 | Drug Interactions | Factor Xa Inhibitors - blood | Pyrazoles - blood | Patient Safety | Aged, 80 and over | Pyridines - administration & dosage | Risk Assessment | Administration, Oral | Risk Factors | Antiviral Agents - administration & dosage | Coronavirus Infections - virology | Antiviral Agents - adverse effects | Factor Xa Inhibitors - adverse effects | Antithrombins - blood | Pneumonia, Viral - diagnosis | Italy | Darunavir - adverse effects | Hemorrhage - chemically induced | Thiazoles - blood | Pandemics | Thiazoles - administration & dosage | Pyridones - administration & dosage | Ritonavir - adverse effects | Female | Pyrazoles - adverse effects | Severity of Illness Index | Coronavirus Infections - diagnosis | Betacoronavirus - drug effects | Dabigatran - blood | Pyrazoles - administration & dosage | Pyridines - blood | Antithrombins - adverse effects | Aged | Drug Monitoring | Pneumonia, Viral - virology | Lopinavir - adverse effects | Pyridones - adverse effects | Anticoagulants | Plasma | Antiviral agents | Ritonavir | Lopinavir | Plasma levels | Hospitalization | Patients | Thrombosis | Index Medicus
Journal Article
Medicinal research reviews, ISSN 0198-6325, 07/2018, Volume 38, Issue 4, pp. 1332 - 1403
heart failure | dysrhythmia | hypertension | stroke | myocardial infarction | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Chemistry, Medicinal | Science & Technology | Vascular Endothelial Growth Factor A | Digoxin - adverse effects | Calcium Channel Blockers - adverse effects | Alkaloids - adverse effects | Cardiovascular Diseases - drug therapy | Humans | Male | Cardiovascular System - drug effects | Hormones - adverse effects | Stroke - drug therapy | Heart Rate - drug effects | Animals | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Arrhythmia Agents - adverse effects | Antineoplastic Agents - adverse effects | Amphetamines - adverse effects | Adrenergic beta-Antagonists - adverse effects | Female | Cardiovascular Diseases - chemically induced | Cocaine - adverse effects | Steroids - adverse effects | Drugs | Index Medicus | Review
Journal Article